Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery

Nephrology Dialysis Transplantation

Volumn 28, Issue 11, 2013, Pages 2787-2799

  Coca, Steven G ^a,b   Garg, Amit X ^c   Swaminathan, Madhav ^d   Garwood, Susan ^a   Hong, Kwangik ^a,b   Thiessen Philbrook, Heather ^c   Passik, Cary ^e,f   Koyner, Jay L ^g   Parikh, Chirag R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Program of Applied Translational Research   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DANBURY HOSPITAL   (United States)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acute renal failure; Biomarkers; Serum creatinine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; GLOMERULUS FILTRATION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ACUTE RENAL FAILURE; BIOMARKERS; SERUM CREATININE;

ACUTE KIDNEY INJURY; ADULT; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INCIDENCE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ANGIOTENSIN; UNITED STATES;

EID: 84890044200     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft405     Document Type: Article

References (44)

1. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006; 1: 19-32
2. Coca SG, Yusuf B, Shlipak MG et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 961-973
3. Kheterpal S, Khodaparast O, Shanks A et al. Chronic angiotensinconverting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 2008; 22: 180-186
4. Bertrand M, Godet G, Meersschaert K et al. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001; 92: 26-30
5. Brabant SM, Bertrand M, Eyraud D et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999; 89: 1388-1392
6. Colson P, Saussine M, Seguin JR et al. Hemodynamic effects of anesthesia in patients chronically treated with angiotensinconverting enzyme inhibitors. Anesth Analg 1992; 74: 805-808
7. Ryckwaert F, Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1997; 84: 945-949
8. Tuman KJ, McCarthy RJ, O'Connor CJ et al. Angiotensinconverting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995; 80: 473-479
9. Comfere T, Sprung J, Kumar MM et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100: 636-644, Table of contents
10. Arora P, Rajagopalam S, Ranjan R et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3: 1266-1273
11. Cittanova ML, Zubicki A, Savu C et al. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analg 2001; 93: 1111-1115
12. Miceli A, Capoun R, Fino C et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2009; 54: 1778-1784
13. Railton CJ, Wolpin J, Lam-McCulloch J et al. Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth 2010; 57: 736-744
14. Ouzounian M, Buth KJ, Valeeva L et al. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ann Thorac Surg 2012; 93: 559-564
15. Rady MY, Ryan T. The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest 1998; 114: 487-494
16. Yoo YC, Youn YN, Shim JK et al. Effects of renin-angiotensin system inhibitors on the occurrence of acute kidney injury following off-pump coronary artery bypass grafting. Circ J 2010; 74: 1852-1858
17. Benedetto U, Sciarretta S, Roscitano A et al. Preoperative angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg 2008; 86: 1160-1165
18. Barodka V, Silvestry S, Zhao N et al. Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery. J Surg Res 2011; 167: e63-e69
19. Nickolas TL, Schmidt-Ott KM, Canetta P et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 2012; 59: 246-255
20. Uchino S, Bellomo R, Bagshaw SM et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 2010; 25: 1833-1839
21. Ralib AM, Pickering JW, Shaw GM et al. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 2012; 23: 322-333
22. Testani JM, Kimmel SE, Dries DL et al. Prognostic importance of early worsening renal function after initiation of angiotensinconverting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail 2011; 4: 685-691
23. Parikh CR, Coca SG, Thiessen-Philbrook H et al. Post-operative biomarkers predict acute kidney injury and poor outcomes after cardiac surgery in adults. J Am Soc Nephrol 2011; 22: 1748-1757
24. Parikh CR, Thiessen Heather P, Garg AX et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 2013; 8: 1079-1088
25. Mehta RL, Kellum JA, Shah SV et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31
26. Parikh CR, Devarajan P, Zappitelli M et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011; 22: 1748-1757
27. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann InternMed 2009; 150: 604-612
28. Grams ME, Astor BC, Bash LD et al. Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury. J Am Soc Nephrol 2010; 21: 1757-1764
29. Nejat M, Pickering JW, Devarajan P et al. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012; 81: 1254-1262
30. Nobes MS, Harris PJ, Yamada H et al. Effects of angiotensin on renal cortical and papillary blood flows measured by laserdoppler flowmetry. Am J Physiol 1991; 261: F998-1006
31. Norman JT, Stidwill R, Singer M et al. Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action. Nephron Physiol 2003; 94: p39-p46
32. Omoro SA, Majid DS, El Dahr SS et al. Roles of ANG II and bradykinin in the renal regional blood flow responses to ACE inhibition in sodium-depleted dogs. Am J Physiol Renal Physiol 2000; 279: F289-F293
33. Tawfik MK. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats. Eur Rev Med Pharmacol Sci 2012; 16: 600-609
34. Molinas SM, Cortes-Gonzalez C, Gonzalez-Bobadilla Y et al. Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury. Nephron Exp Nephrol 2009; 112: e10-e19
35. Mejia-Vilet JM, Ramirez V, Cruz C et al. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 2007; 293: F78-F86
36. Krishan P, Sharma A, Singh M. Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats. Pharmacol Res 1998; 37: 23-29
37. Haase M, Devarajan P, Haase-Fielitz A et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1752-1761
38. Testani JM, Chen J, McCauley BD et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122: 265-272
39. Testani JM, Coca SG, McCauley BD et al. Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail 2011; 13: 877-884
40. Bell CM, Brener SS, Gunraj N et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011; 306: 840-847
41. Ishani A, Qadri G, Solid C. Antihypertensive medication use before and after acute kidney injury in general medicare patients. J Am Soc Nephrol 2012; 23: 664A
42. ThomasMC, Jerums G, Tsalamandris Cet al.; MDNSG Study Group. Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes. Kidney Int 2005; 67: 2494-2499.
43. Virani SS, Nambi V, Polsani VR et al. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther 2010; 28: 80-86
44. Liakopoulos OJ, Kuhn EW, Slottosch I et al. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev 2012; 4: CD008493.